D. E. Shaw & Co., Inc. Pmv Pharmaceuticals, Inc. Transaction History
D. E. Shaw & Co., Inc.
- $114 Billion
- Q1 2024
A detailed history of D. E. Shaw & Co., Inc. transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 720,635 shares of PMVP stock, worth $1.31 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
720,635
Previous 248,505
189.99%
Holding current value
$1.31 Million
Previous $770,000
59.09%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding PMVP
# of Institutions
106Shares Held
45.5MCall Options Held
2KPut Options Held
600-
Orbimed Advisors LLC San Diego, CA6.48MShares$11.8 Million0.25% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.2MShares$5.82 Million0.07% of portfolio
-
Black Rock Inc. New York, NY3.11MShares$5.66 Million0.0% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$4.78 Million0.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.45MShares$4.46 Million0.0% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $83M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...